ATE415943T1 - Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff - Google Patents

Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff

Info

Publication number
ATE415943T1
ATE415943T1 AT99922371T AT99922371T ATE415943T1 AT E415943 T1 ATE415943 T1 AT E415943T1 AT 99922371 T AT99922371 T AT 99922371T AT 99922371 T AT99922371 T AT 99922371T AT E415943 T1 ATE415943 T1 AT E415943T1
Authority
AT
Austria
Prior art keywords
cetyl alcohol
polyproxylated
active ingredient
pharmaceutical preparations
preparations containing
Prior art date
Application number
AT99922371T
Other languages
English (en)
Inventor
Brian Hawtin
Original Assignee
Thornton & Ross Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thornton & Ross Ltd filed Critical Thornton & Ross Ltd
Application granted granted Critical
Publication of ATE415943T1 publication Critical patent/ATE415943T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99922371T 1998-05-22 1999-05-20 Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff ATE415943T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810949.9A GB9810949D0 (en) 1998-05-22 1998-05-22 Formulation

Publications (1)

Publication Number Publication Date
ATE415943T1 true ATE415943T1 (de) 2008-12-15

Family

ID=10832479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922371T ATE415943T1 (de) 1998-05-22 1999-05-20 Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff

Country Status (13)

Country Link
US (1) US7109246B1 (de)
EP (1) EP1079804B1 (de)
JP (2) JP4230109B2 (de)
AT (1) ATE415943T1 (de)
AU (1) AU3946899A (de)
CA (1) CA2330330C (de)
CY (1) CY1108659T1 (de)
DE (1) DE69940015D1 (de)
DK (1) DK1079804T3 (de)
ES (1) ES2320054T3 (de)
GB (2) GB9810949D0 (de)
PT (1) PT1079804E (de)
WO (1) WO1999060997A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
CA2408541C (en) * 2000-05-12 2009-07-28 Meracol Corporation Limited Treating eczema and/or psoriasis
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
GB0310147D0 (en) * 2003-05-02 2003-06-04 Almond Julie E A composition for use in the treatment of a skin condition in a subject
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
CN1968704B (zh) * 2004-05-19 2010-12-08 爱密斯菲尔科技公司 局部用色甘酸制剂
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2008154705A1 (en) * 2007-06-20 2008-12-24 Apollo Life Sciences Limited Transdermal delivery of active agents
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
JP5930953B2 (ja) * 2011-12-14 2016-06-08 花王株式会社 抗菌剤組成物の製造方法
JP2015510914A (ja) * 2012-03-19 2015-04-13 ドクトア・アウグスト・ボルフ・ゲーエムベーハー・ウント・コンパニー・カー・ゲー−アルツナイミツテル 膣感染症における病原性膣バイオフィルムの予防及び治療のための両性界面活性剤の使用
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) * 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
ES2792682T3 (es) 2014-02-10 2020-11-11 Respivant Sciences Gmbh Métodos para el tratamiento de enfermedades pulmonares con estabilizadores de mastocitos
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
WO2018044942A1 (en) 2016-08-31 2018-03-08 Patara Pharma, LLC Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
EP3522983A4 (de) 2016-10-07 2020-06-03 Respivant Sciences GmbH Cromolynzusammensetzung zur behandlung von lungenfibrose
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
GB2587402B (en) * 2019-09-27 2023-05-10 Hewlett Healthcare Ltd Formulation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974270A (en) 1972-11-03 1976-08-10 Colgate-Palmolive Company Pressurized composition for the production of a dry spray of mild but effective non-staining antiperspirant
HK38179A (en) 1973-12-19 1979-06-22 Fisons Ltd Topical compositions
GB1537047A (en) 1975-10-03 1978-12-29 Fisons Ltd Eye ointment
FR2546407B1 (fr) * 1983-05-24 1986-04-18 Therapeutique Applic Sa Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique
JPS6261929A (ja) * 1985-09-13 1987-03-18 Showa Denko Kk 水溶性薬物の経皮吸収性を高めた皮膚外用剤
EP0189861A3 (de) 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Transdermaler Absorptionsbeschleuniger für ionische wasserlösliche Arzneistoffe
DE3583237D1 (de) 1985-07-10 1991-07-18 Richardson Gmbh Reinigungsschaum fuer zaehne.
US5190917A (en) * 1986-12-24 1993-03-02 John Lezdey Treatment of psoriasis
JPS63230641A (ja) * 1987-03-19 1988-09-27 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用製剤
GB2202145B (en) 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
GB8912391D0 (en) * 1989-05-30 1989-07-12 Unilever Plc Shampoo composition
US5100908A (en) * 1990-03-06 1992-03-31 Ss Pharmaceutical Co., Ltd. Antimycotic external imidazole preparations
US5696110A (en) * 1991-10-24 1997-12-09 Merck, Sharp & Dohme, Ltd. Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5254109A (en) * 1992-12-07 1993-10-19 Creative Products Resource Associates, Ltd. Separately packaged applicator pads for topical delivery of incompatable drugs
FR2699169B1 (fr) * 1992-12-16 1995-02-03 Oreal Nouveaux sels d'amines primaires dérivés d'acides aminés à groupement uréthanne, et leur utilisation dans des compositions cosmétiques.
JPH06305934A (ja) * 1993-04-23 1994-11-01 Pola Chem Ind Inc エアゾール型化粧料
US6231844B1 (en) * 1995-04-13 2001-05-15 The Procter & Gamble Company Nonionic surfactant foaming agents for foaming cosmetic compositions
JPH08319212A (ja) * 1995-05-24 1996-12-03 Kanebo Ltd エアゾール組成物
JPH09157172A (ja) 1995-12-13 1997-06-17 Lion Corp 皮膚外用剤及び湿疹薬
JPH09157161A (ja) 1995-12-13 1997-06-17 Lion Corp 皮膚疾患治療剤
WO1997027838A1 (en) * 1996-02-02 1997-08-07 Estee Lauder, Inc. Skin smoothing compositions containing hydroxyacids and methods for using same
FR2745496B1 (fr) * 1996-03-01 1998-04-30 Oreal Dispositif pressurise transparent a composition moussante comprenant des tensioactifs non-ioniques et amphoteres
CN1138515C (zh) * 1996-03-08 2004-02-18 迪斯珀斯有限公司 包含一种油基双液体泡沫和一种水凝胶的分散体系
US6143310A (en) * 1996-06-27 2000-11-07 The Procter & Gamble Company Cosmetic compositions
US5837274A (en) * 1996-10-22 1998-11-17 Kimberly Clark Corporation Aqueous, antimicrobial liquid cleaning formulation
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6150403A (en) * 1997-10-14 2000-11-21 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US6207694B1 (en) * 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6177092B1 (en) * 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems

Also Published As

Publication number Publication date
GB2337461B (en) 2003-10-01
DK1079804T3 (da) 2009-03-30
ES2320054T3 (es) 2009-05-18
WO1999060997A1 (en) 1999-12-02
GB2337461A (en) 1999-11-24
GB9810949D0 (en) 1998-07-22
AU3946899A (en) 1999-12-13
JP2008273985A (ja) 2008-11-13
GB9911733D0 (en) 1999-07-21
JP2002530271A (ja) 2002-09-17
JP4230109B2 (ja) 2009-02-25
DE69940015D1 (de) 2009-01-15
CA2330330C (en) 2009-09-15
EP1079804B1 (de) 2008-12-03
CA2330330A1 (en) 1999-12-02
EP1079804A1 (de) 2001-03-07
US7109246B1 (en) 2006-09-19
PT1079804E (pt) 2009-02-05
CY1108659T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
PT977555E (pt) Preparacoes farmaceuticas e metodos para a sua administracao localmente
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
NO20031249D0 (no) Emulsjonspreparater samt konsentrater derav
PT918507E (pt) Formulacoes em aerossol
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
DE50012930D1 (de) Emulgatorfreie feindisperse systeme vom typ wasser-in-öl
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
WO2004075867A3 (de) Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend
WO2021255483A1 (en) Composition for topical dermatological delivery
MY110074A (en) Pharmacuetical formulation.
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
BR0108732A (pt) Composição farmacêutica para a prevenção e tratamento da progressão da fibrose e cirrose hepática, seu uso e método para a prevenção e tratamento da fibrose e cirrose hepática
DE69926633D1 (de) Injizierbare arzneiformulierungen von partricin derivaten
DE69228970D1 (de) Dithranol enthaltendes Arzneimittel zur topischen Anwendung sowie Herstellungsverfahren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1079804

Country of ref document: EP